1. "2014"
Formats
  1. Journal Article (2603)
  2. Meeting Abstract (1417)
  3. Book Section (235)
  4. Conference Paper (23)
  5. Book Whole (16)
  6. Review (3)
Groups
  1. Department of Medicine (1584)
  2. GSK Faculty (1082)
  3. Surgery (895)
  4. Solid Tumor Oncology Division (840)
  5. Center for Hematologic Malignancies (703)
  6. Sloan Kettering Institute Faculty (672)

More Groups

People
  1. Jedd Wolchok (71)
  2. Sergio Giralt (71)
  3. Ross Levine (69)
  4. Martin Tallman (62)
  5. Michael Berger (59)
  6. Mithat Gonen (55)

More People

Years
  1. 2014 (4297)
Publications
  1. Journal of Clinical Oncology (420)
  2. Blood (228)
  3. International Journal of Radiation Oncology, Biology, Physics (131)
  4. Cancer Research (104)
  5. Modern Pathology (89)
  6. Laboratory Investigation (82)

More Publications

Publishers
  1. Elsevier Inc. (495)
  2. American Society of Clinical Oncology (446)
  3. Springer (318)
  4. Elsevier Science, Inc. (246)
  5. Nature Publishing Group (242)
  6. American Society of Hematology (230)

More Publishers

Results (4297)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Specific and recurrent cytogenomic abnormalities originate in the spleens of myelofibrosis patients and contribute to clonal diversity and disease progression
    Meeting Abstract

    Najfeld, V.; Tripodi, J.; Wang, X. L.; Schwartz, M.; Kremyanskaya, M.; Cytryn, E.; Zirkiev, S.; Rampal, R. K.; Mascarenhas, J. O.; Hoffman, R.
    Blood (2014)

    Fulltext@MSK | Save
  • Prediction of CD34(+) hematopoietic progenitor cell harvest yield in multiple myeloma patients mobilized with G-CF and plerixafor
    Meeting Abstract

    Moung, C.; Avecilla, S. T.; Meagher, R. C.; Reich, L.; Maslak, P.
    Transfusion (2014)

    Fulltext@MSK | Save
  • PD-1 blockade with the monoclonal antibody pembrolizumab (MK-3475) in patients with classical Hodgkin lymphoma after brentuximab vedotin failure: Preliminary results from a phase 1b study (KEYNOTE-013)
    Meeting Abstract

    Moskowitz, C. H.; Ribrag, V.; Michot, J. M.; Martinelli, G.; Zinzani, P. L.; Gutierrez, M.; De Maeyer, G.; Jacob, A. G.; Giallella, K.; Anderson, J. W.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • The AETHERA trial: Results of a randomized, double-blind, placebo-controlled phase 3 study of brentuximab vedotin in the treatment of patients at risk of progression following autologous stem cell transplant for Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, C. H.; Nadamanee, A.; Masszi, T.; Agura, E.; Holowiecki, J.; Abidi, M. H.; Chen, A. I.; Stiff, P. J.; Gianni, A. M.; Carella, A. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Interim analysis of a phase 1 study of the antibody-drug conjugate SGN-CD19A in relapsed or refractory B-lineage non-Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, C. H.; Forero-Torres, A.; Shah, B. D.; Advani, R.; Hamlin, P.; Kim, S.; Kostic, A.; Sandalic, L.; Zhao, B. T.; Fanale, M. A.
    Blood (2014)

    Fulltext@MSK | Save
  • Denosumab therapy for the treatment of persistentor relapsed hypercalcemia of malignancy (HCM)
    Meeting Abstract

    Misiorowski, W.; Hu, M.; Glezerman, I.; Leboulleux, S.; Insogna, K.; Gucalp, R.; Yu, B.; Zorsky, P.; Tosi, D.; Bessudo, A.; more...
    Osteoporosis International (2014)

    Fulltext@MSK | Save
  • Type II inhibition of JAK2 with NVP-CHZ868 reverses type I JAK inhibitor persistence and demonstrates increased efficacy in MPN models
    Meeting Abstract

    Meyer, S. C.; Keller, M. D.; Koppikar, P.; Guryanova, O. A.; Kleppe, M.; McKenney, A. S.; Sellers, W. R.; Hofmann, F.; Baffert, F.; Gaul, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Bone marrow core biopsy adequacy and variability in the United Stated and Canada: A multicenter retrospective study
    Meeting Abstract

    Merzianu, M.; Cheney, R.; Groman, A.; Deeb, G.; Wilding, G.; Cotta, C.; Amre, R.; Balasubramanian, M.; Brandao, G.; Brynes, R. K.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Distinct DNA methylation and expression profiles underlie CMML responsiveness to decitabine and uncover novel mechanism of resistance
    Meeting Abstract

    Meldi, K.; Qin, T. T.; Buchi, F.; Micol, J. B.; Sotzen, J.; Masala, E.; Allione, B.; Gioia, D.; Poloni, A.; Lunghi, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Deep molecular response in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with nilotinib: ENESTnext update
    Meeting Abstract

    Mauro, M. J.; Dakhil, S.; Cortes, J. E.; Rizzieri, D. A.; Keir, C. H.; Yi, S.; Heinrich, M. C.; Goldberg, S. L.; Catchatourian, R.; Kuriakose, P.; more...
    Blood (2014)

    Fulltext@MSK | Save